1. Home
  2. CPRX vs UTF Comparison

CPRX vs UTF Comparison

Compare CPRX & UTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • UTF
  • Stock Information
  • Founded
  • CPRX 2002
  • UTF 2004
  • Country
  • CPRX United States
  • UTF United States
  • Employees
  • CPRX N/A
  • UTF N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • UTF Finance Companies
  • Sector
  • CPRX Health Care
  • UTF Finance
  • Exchange
  • CPRX Nasdaq
  • UTF Nasdaq
  • Market Cap
  • CPRX 2.5B
  • UTF 2.5B
  • IPO Year
  • CPRX 2006
  • UTF N/A
  • Fundamental
  • Price
  • CPRX $22.34
  • UTF $23.65
  • Analyst Decision
  • CPRX Strong Buy
  • UTF
  • Analyst Count
  • CPRX 7
  • UTF 0
  • Target Price
  • CPRX $31.14
  • UTF N/A
  • AVG Volume (30 Days)
  • CPRX 820.3K
  • UTF 266.0K
  • Earning Date
  • CPRX 11-06-2024
  • UTF 01-01-0001
  • Dividend Yield
  • CPRX N/A
  • UTF 8.21%
  • EPS Growth
  • CPRX 114.68
  • UTF N/A
  • EPS
  • CPRX 1.18
  • UTF N/A
  • Revenue
  • CPRX $460,482,000.00
  • UTF N/A
  • Revenue This Year
  • CPRX $23.98
  • UTF N/A
  • Revenue Next Year
  • CPRX $18.27
  • UTF N/A
  • P/E Ratio
  • CPRX $18.72
  • UTF N/A
  • Revenue Growth
  • CPRX 32.17
  • UTF N/A
  • 52 Week Low
  • CPRX $13.12
  • UTF $18.15
  • 52 Week High
  • CPRX $24.27
  • UTF $24.49
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 54.94
  • UTF 25.75
  • Support Level
  • CPRX $20.93
  • UTF $23.54
  • Resistance Level
  • CPRX $22.49
  • UTF $24.97
  • Average True Range (ATR)
  • CPRX 0.60
  • UTF 0.31
  • MACD
  • CPRX 0.00
  • UTF -0.23
  • Stochastic Oscillator
  • CPRX 77.06
  • UTF 3.99

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.

About UTF Cohen & Steers Infrastructure Fund Inc

Cohen & Steers Infrastructure Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is total return with an emphasis on income. It invests majority of its managed assets in securities issued by infrastructure companies, which consists of utilities, pipelines, toll roads, airports, railroads, ports, telecommunications companies, and other infrastructure companies, under normal market conditions.

Share on Social Networks: